Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Cancer Research|March 17, 2007
Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenomaEmmanuelle Jeannot, Karine Poussin, Laurence Chiche, et al.Plos One|April 6, 2012
Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosisMarion Depla, Louis d'Alteroche, Amélie Le Gouge, et al.Oncoimmunology|February 7, 2014
Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenomaKarine Poussin, Camilla Pilati, Gabrielle Couchy, et al.Journal of Gastroenterology|May 18, 2013
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis CJérôme Boursier, Victor de Ledinghen, Nathalie Sturm, et al.Hepatology (Baltimore, Md.)|February 24, 2006
Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCCJessica Zucman-Rossi, Emmanuelle Jeannot, Jeanne Tran Van Nhieu, et al.The Lancet. Gastroenterology & Hepatology|April 14, 2017
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trialMarc Bourlière, Pascaline Rabiega, Nathalie Ganne-Carrie, et al.Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.Gastroenterology|July 22, 2018
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance ProgramsPierre Nahon, Richard Layese, Valérie Bourcier, et al.Hepatology (Baltimore, Md.)|June 28, 2016
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)Nathalie Ganne-Carrié, Richard Layese, Valérie Bourcier, et al.Pageof 5